NASDAQ · TEM

Tempus AI, Inc.

Healthcare · Medical - Healthcare Information Services

$76.63▲ 0.17% ($0.13)at close

After hours$76.73▲ 0.13%7:59 PM ET

52-week

$40.77$104.32

Valuation

Earnings yield

No estimate

Earnings yield isn't available here

A positive earnings figure and a usable price are needed to calculate earnings yield.

USD · Financial statements through Jun 30, 2026 · EPS source period not supplied · Price used $76.63 · Price Oct 2, 8:00 PM UTC

Your edits update the card above as you go.

Earnings yield · Maximum entry price

Unavailable

Projected annual return:: Unavailable
Current earnings yield:: Unavailable
10-year Treasury benchmark:: 5.28%

Entry price is a return-based threshold, not an estimate of value.

A positive earnings figure and a usable price are needed to calculate earnings yield.

USD · Financial statements through 2026-06-30 · EPS source period not supplied

Estimate an entry price from future earnings and your required return. Growth and the exit P/E change the forecast; current earnings yield uses only EPS and the price used.

Earnings per sharePer share · USD

Annual EPS growth percent

Target price-to-earnings multiple

Holding period in years

Required annual return percent

Add a positive EPS and exit P/E, and an EPS growth assumption to calculate the forecast.

EPS basis: reported EPS unavailable in the price currency. Current earnings yield: —. Dividends are excluded from projected annual return.

Price vs Fundamentals

Why The Stock Is Moving

Likely multiple compressionModerate confidence

Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.

1Y Price: -14.19%Revenue (TTM): 50.43%FCF (TTM): -274.27%P/S: 56th pct

What changed

The stock fell 14.19% over the last year. Revenue grew 50.43% over the trailing twelve months. Operating margin moved from -24.66% to -19.76%. Free cash flow declined 274.27% over the trailing twelve months.

What the market seems to be pricing

Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.

What would invalidate this read

This read changes if operating margin (currently -19.76%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.

Return analysis

Company profile

Tempus AI, Inc. operates as a healthcare technology company in the United States.

CEOEric Lefkofsky

SectorHealthcare

IndustryMedical - Healthcare Information Services

Employees3,800

IPO dateJun 14, 2024

https://www.tempus.com

Market multiples

Forward P/E—

EV/EBITDA (FY2025 year-end)-92.93

Enterprise value (FY2025 year-end)$11.01B

Stock splits

No stock splits recorded for this ticker.

Profitability & growth

Revenue growth (Q2 FY26 YoY)21.56%

Gross margin (FY2025)62.74%▲7.8ppvs FY2024

Operating margin (FY2025)-19.88%▲79.8ppvs FY2024

ROE-67.44%▲22.0ppvs FY2025

Analyst consensus

RatingBuy

Target price$72.60▼5.26%

Buy

Hold

Sell

Analyst ratings tend to be lagging indicators. Use as one signal among many.

Earnings

Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.

Next report

Nov 3, 2026

Q3 FY26 · EPS est -$0.07 · Revenue est $409.42M

View

Institutional Sentiment

Tempus AI, Inc. · TEM

From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.

NASDAQ · TEM

Tempus AI, Inc.

Healthcare · Medical - Healthcare Information Services

$76.63▲ 0.17% ($0.13)at close

After hours$76.73▲ 0.13%7:59 PM ET

52-week

$40.77$104.32

Valuation

Earnings yield

No estimate

Earnings yield isn't available here

A positive earnings figure and a usable price are needed to calculate earnings yield.

USD · Financial statements through Jun 30, 2026 · EPS source period not supplied · Price used $76.63 · Price Oct 2, 8:00 PM UTC

Your edits update the card above as you go.

Earnings yield · Maximum entry price

Unavailable

Projected annual return:: Unavailable
Current earnings yield:: Unavailable
10-year Treasury benchmark:: 5.28%

Entry price is a return-based threshold, not an estimate of value.

A positive earnings figure and a usable price are needed to calculate earnings yield.

USD · Financial statements through 2026-06-30 · EPS source period not supplied

Estimate an entry price from future earnings and your required return. Growth and the exit P/E change the forecast; current earnings yield uses only EPS and the price used.

Earnings per sharePer share · USD

Annual EPS growth percent

Target price-to-earnings multiple

Holding period in years

Required annual return percent

Add a positive EPS and exit P/E, and an EPS growth assumption to calculate the forecast.

EPS basis: reported EPS unavailable in the price currency. Current earnings yield: —. Dividends are excluded from projected annual return.

Price vs Fundamentals

Why The Stock Is Moving

Likely multiple compressionModerate confidence

Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.

1Y Price: -14.19%Revenue (TTM): 50.43%FCF (TTM): -274.27%P/S: 56th pct

What changed

What the market seems to be pricing

Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.

What would invalidate this read

This read changes if operating margin (currently -19.76%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.

Return analysis

Company profile

Tempus AI, Inc. operates as a healthcare technology company in the United States.

CEOEric Lefkofsky

SectorHealthcare

IndustryMedical - Healthcare Information Services

Employees3,800

IPO dateJun 14, 2024

https://www.tempus.com

Market multiples

Forward P/E—

EV/EBITDA (FY2025 year-end)-92.93

Enterprise value (FY2025 year-end)$11.01B

Stock splits

No stock splits recorded for this ticker.

Profitability & growth

Revenue growth (Q2 FY26 YoY)21.56%

Gross margin (FY2025)62.74%▲7.8ppvs FY2024

Operating margin (FY2025)-19.88%▲79.8ppvs FY2024

ROE-67.44%▲22.0ppvs FY2025

Analyst consensus

RatingBuy

Target price$72.60▼5.26%

Buy

Hold

Sell

Analyst ratings tend to be lagging indicators. Use as one signal among many.

Earnings

Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.

Next report

Nov 3, 2026

Q3 FY26 · EPS est -$0.07 · Revenue est $409.42M

View

Institutional Sentiment

Tempus AI, Inc. · TEM

From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.